Austin, Texas, United States, June 20th, 2025, FinanceWire
HeartBeam (NASDAQ: BEAT) has received FDA 510(k) clearance for its flagship ECG system, a first-of-its-kind, credit card-sized, cable-free device designed to provide high-fidelity, three-directional cardiac recordings for arrhythmia evaluation. The clearance is a major regulatory milestone and speeds up HeartBeam’s plans to improve access to timely, remote cardiac care.
When symptoms occur, patients use the app-guided system to record a 30-second ECG, which is uploaded automatically to the cloud so a physician can review it alongside the patient’s medical history. The company will shortly launch an Early Access Program to involve early adopters and providers ahead of broader commercialization.
The clearance also lays the groundwork for future advances, including 12-lead ECG synthesis, AI-based arrhythmia detection and remote heart attack risk scoring. HeartBeam’s long-term vision is to revolutionize cardiac care by enabling continuous, predictive insights outside traditional clinical settings.
The full press release can be read at https://ibn.fm/go8CI
About HeartBeam Inc.
HeartBeam is a medical technology company focused on transforming cardiac care by delivering powerful cardiac insights wherever the patient is. It is developing the first-ever cable-free 12-lead ECG, able to capture the heart’s electrical signals from three dimensions. The platform technology is designed for portable devices that can be used wherever the patient is to provide actionable heart intelligence. Physicians will be able to identify cardiac health trends and acute conditions and direct patients to the appropriate care, all outside of a medical facility, thus redefining the future of cardiac health management. The company holds 13 U.S. and 4 international-issued patents related to technology enablement. Further information is available at www.HeartBeam.com
NOTE TO INVESTORS: IBN is a multifaceted financial news, content creation and publishing company used by public and private companies alike to build investor awareness and recognition. More information can be found at https://www.InvestorBrandNetwork.com
The full terms of use and disclaimers that apply to all content provided by IBN, wherever it is published or re-published, are set out on the InvestorBrandNetwork website: http://IBN.fm/Disclaimer
The latest news and updates relating to BEAT can be found in the company’s newsroom at https://ibn.fm/BEAT
Corporate Communications
IBN
Austin, Texas
www.InvestorBrandNetwork.com
512.354.7000 Office
Editor@InvestorBrandNetwork.com
Contact
IBN
www.InvestorBrandNetwork.com
Editor@InvestorBrandNetwork.com
